Jose headshot

Jose A Caparros-Martin, PhD

Data analysis · Genomics · Reproducible research

About me

This site summarizes my work across biology, biotechnology, and data science, including my training, experience, publications, and projects.

I hold a degree in Biology and a PhD in Biotechnology. My early research focused on molecular genetics, where I contributed to identifying genes associated with rare human developmental disorders, with an emphasis on research that can translate into clinical and societal benefit.

After moving to Australia, I helped establish the Human Microbiome Collaboration Centre at Curtin University. There, I worked on microbiome profiling as a marker of disease and its potential for earlier detection, monitoring, and prevention in chronic conditions.

More recently, my work has increasingly leaned into computational approaches. I am especially focused on bioinformatics and applied machine learning, including language models and multi-agent systems, to extract insight from complex biological data and improve biomedical research workflows.

Outside of work, I spend time with my family and enjoy astronomy, fossil collecting, and exploring Western Australia.

Education

CSAIP (Data Science and AI)
Curtin University & Institute of Data — 2025
  • Skills: Statistics and programming for data science, Databases and API, Machine learning (regression, classification, clustering), Natural language models, AI and Deep learning, Cloud computing.
PhD in Biotechnology
Molecular and Cell Biology Institute (IBMCP-CSIC). Polytechnic University of Valencia-UPV (Spain) — 2006
  • Excellent Cum laude.
BSc in Biology
University of Alicante — 2002

Experience

Research Fellow at The Telethon Kids Institute
2020 — 2025
  • Built reproducible multi-omics pipelines (version-controlled workflows, documented outputs, automated reporting).
  • Trained and mentored HDR students; supported project design, analysis, and reproducibility practices.
  • Contributed to centre governance as a member of the Wal-yan Respiratory Research Centre strategic subcommittee.
  • Partnered with consumer/community groups to keep research priorities patient-focused.
  • Emerging Leaders Program (2024): co-developed a risk & compliance playbook (stakeholder mapping, rollout roadmap, evaluation metrics, ongoing compliance processes).
  • Co-authored 24 peer-reviewed publications in this appointment.
Research Fellow at Curtin University
2016 — 2020
  • Co-founded the Human Microbiome Collaboration Centre; built standardized SOPs and reproducible computational pipelines for microbiome analyses.
  • Led/ coordinated multi-institutional collaborations and pilot projects; supervised and mentored students.
  • Co-authored 12 peer-reviewed papers during this role.
Postdoctoral researcher at CIBERER IIBM-UAM (Madrid, Spain)
2008 — 2015
  • Worked on international rare-disease genomics programs, helping translate sequencing data into clinical insights.
  • Trained and supervised HDR students (analysis, pipelines, reproducibility).
  • Co-authored 17 peer-reviewed papers during this role.

Publications

Loading...

Projects

Predicting Suicide Risk Using Machine Learning and Large Language Models

This project explores traditional machine learning (ML) and large language models (LLMs) to classify sentences by suicide risk using a labeled dataset from Kaggle, aiming to detect language patterns associated with suicidal ideation.

Repo: GitHub Repo

Nasal bacteria predictors of wheezing phenotypes

Pilot study evaluating whether early-life nasal microbiota from healthy infants predicts wheezing in the first year of life.

Preprint: MedRxiv link

Repo: AERIAL microbiota

Molecular pathways and mechanisms of the gut–lung axis in chronic lung diseases

In this project, we investigated the molecular pathways underlying the gut–lung axis in chronic lung diseases to identify potential therapeutic targets. We identified gut microbiota–derived metabolites that modulate lung inflammation and immune responses in cystic fibrosis and other chronic lung diseases. We published multiple papers and presented these findings at international conferences. Below are examples of our work in this area.

Bile acids and early inflammation in CF lung disease - findings from the COMBAT CF cohort: Caparros-Martin et al. Microbiome (2023)

Bile acids and airway microbiota remodeling in COPD: Caparros-Martin et al. BMJ Open Resp Res (2024)

Liver Nuclear Receptors as Drivers of Host–Microbiota Crosstalk

In this project, We studied how activation of liver nuclear receptors can reshape the gut microbiota and influence downstream physiology, including metabolic outcomes. Because these receptors are commonly triggered by drugs, diet-derived compounds, and other xenobiotics, this host-driven modulation of the microbiota has direct implications for human health and therapeutic responses.

Nuclear receptor–gut microbiota interactions in response to statin therapy: Caparros-Martin et al. Microbiome (2017)

Gene Discovery and Molecular Pathogenesis in Rare Skeletal Disorders

During my postdoctoral training in molecular genetics, I led projects to identify causative genes and define disease mechanisms across rare human disorders, with a focus on skeletal dysplasias (including short-rib polydactyly syndromes and osteogenesis imperfecta). I also contributed to studies in congenital multiminicore myopathy and Neu-Laxova syndrome. In parallel, I investigated how the Ellis–van Creveld (EVC/EVC2) complex functions in primary cilia to mediate Hedgehog signalling. Below are examples of our work in this area.

The role of the EVC/EVC2 complex in Hedgehog signaling and skeletal development: Caparros-Martin et al. Human Molecular Genetics (2013)

Identification and molecular characterization of BMP1 mutations in osteogenesis imperfecta: Martinez-Glez et al. Human Mutation (2012)

Contact